Colinz Laboratories Limited (COLINZ.BO)
INR 55.65
(5.0%)
INR 55.65
(5.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 16.35 Million INR | -63.94% |
| 2022 | 45.35 Million INR | 3.99% |
| 2021 | 43.61 Million INR | 18.72% |
| 2020 | 36.73 Million INR | -19.9% |
| 2019 | 45.86 Million INR | 0.34% |
| 2018 | 45.7 Million INR | -2.34% |
| 2017 | 46.8 Million INR | 10.02% |
| 2016 | 42.54 Million INR | -7.09% |
| 2015 | 45.79 Million INR | 7.53% |
| 2014 | 42.58 Million INR | 4.65% |
| 2013 | 40.69 Million INR | -6.01% |
| 2012 | 43.29 Million INR | 10.34% |
| 2011 | 39.23 Million INR | 11.3% |
| 2010 | 35.25 Million INR | 29.34% |
| 2009 | 27.25 Million INR | -13.25% |
| 2008 | 31.42 Million INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 4.34 Million INR | 8.43% |
| 2024 Q2 | 5.4 Million INR | 24.46% |
| 2023 Q2 | 3.77 Million INR | -70.92% |
| 2023 Q3 | 11.73 Million INR | 210.43% |
| 2023 FY | 16.35 Million INR | -63.94% |
| 2023 Q1 | 12.99 Million INR | 57.2% |
| 2023 Q4 | 4 Million INR | -65.83% |
| 2022 Q1 | 12.67 Million INR | 79.43% |
| 2022 Q3 | 11.79 Million INR | -6.48% |
| 2022 Q4 | 8.26 Million INR | -29.93% |
| 2022 FY | 45.35 Million INR | 3.99% |
| 2022 Q2 | 12.61 Million INR | -0.47% |
| 2021 FY | 43.61 Million INR | 18.72% |
| 2021 Q1 | 12.51 Million INR | 52.46% |
| 2021 Q2 | 13.11 Million INR | 4.81% |
| 2021 Q3 | 10.93 Million INR | -16.64% |
| 2021 Q4 | 7.06 Million INR | -35.4% |
| 2020 Q2 | 10.33 Million INR | 38.85% |
| 2020 Q1 | 7.44 Million INR | -11.9% |
| 2020 Q3 | 10.75 Million INR | 4.06% |
| 2020 Q4 | 8.2 Million INR | -23.65% |
| 2020 FY | 36.73 Million INR | -19.9% |
| 2019 Q1 | 12.96 Million INR | 101.5% |
| 2019 FY | 45.86 Million INR | 0.34% |
| 2019 Q4 | 8.44 Million INR | -31.49% |
| 2019 Q3 | 12.33 Million INR | 1.76% |
| 2019 Q2 | 12.11 Million INR | -6.56% |
| 2018 FY | 45.7 Million INR | -2.34% |
| 2018 Q4 | 6.43 Million INR | -51.7% |
| 2018 Q3 | 13.32 Million INR | 6.34% |
| 2018 Q2 | 12.53 Million INR | -6.6% |
| 2018 Q1 | 13.41 Million INR | -11.52% |
| 2017 FY | 46.8 Million INR | 10.02% |
| 2017 Q3 | 12.7 Million INR | 4.98% |
| 2017 Q2 | 12.1 Million INR | -3.87% |
| 2017 Q4 | 15.16 Million INR | 19.37% |
| 2017 Q1 | 12.58 Million INR | 7.5% |
| 2016 Q2 | 14.35 Million INR | 14.91% |
| 2016 Q1 | 12.48 Million INR | 15.49% |
| 2016 Q4 | 11.7 Million INR | 2.85% |
| 2016 Q3 | 11.38 Million INR | -20.67% |
| 2016 FY | 42.54 Million INR | -7.09% |
| 2015 Q4 | 10.81 Million INR | -4.0% |
| 2015 Q2 | 11.87 Million INR | -2.42% |
| 2015 Q3 | 11.26 Million INR | -5.12% |
| 2015 FY | 45.79 Million INR | 7.53% |
| 2015 Q1 | 12.16 Million INR | 17.36% |
| 2014 Q2 | 11.73 Million INR | 5.37% |
| 2014 Q1 | 11.13 Million INR | 21.98% |
| 2014 Q4 | 10.36 Million INR | -13.33% |
| 2014 FY | 42.58 Million INR | 4.65% |
| 2014 Q3 | 11.96 Million INR | 1.93% |
| 2013 Q2 | 10.27 Million INR | -5.92% |
| 2013 Q4 | 9.13 Million INR | -11.92% |
| 2013 FY | 40.69 Million INR | -6.01% |
| 2013 Q1 | 10.92 Million INR | 15.31% |
| 2013 Q3 | 10.36 Million INR | 0.91% |
| 2012 Q4 | 9.47 Million INR | -12.59% |
| 2012 Q2 | 11.52 Million INR | 0.54% |
| 2012 FY | 43.29 Million INR | 10.34% |
| 2012 Q1 | 11.46 Million INR | 26.82% |
| 2012 Q3 | 10.83 Million INR | -5.98% |
| 2011 Q3 | 9.95 Million INR | 0.0% |
| 2011 Q4 | 9.03 Million INR | -9.19% |
| 2011 FY | 39.23 Million INR | 11.3% |
| 2010 FY | 35.25 Million INR | 29.34% |
| 2009 Q4 | 7.78 Million INR | 0.0% |
| 2009 FY | 27.25 Million INR | -13.25% |
| 2008 FY | 31.42 Million INR | 0.0% |
| 2008 Q4 | 8.13 Million INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| ANG Lifesciences India Limited | 232.73 Million INR | 92.973% |
| Bacil Pharma Limited | -19.95 Thousand INR | 82079.95% |
| BDH Industries Limited | 175.55 Million INR | 90.684% |
| Beryl Drugs Limited | 108.5 Million INR | 84.927% |
| Cian Healthcare Limited | 113.16 Million INR | 85.548% |
| Chemo Pharma Laboratories Limited | 18.38 Million INR | 11.027% |
| Deccan Health Care Limited | 221.57 Million INR | 92.619% |
| DECIPHER LABS LIMITED | 331.34 Million INR | 95.064% |
| Add-Shop E-Retail Limited | 224.09 Million INR | 92.702% |
| Concord Drugs Limited | 116.7 Million INR | 85.986% |
| Gujarat Terce Laboratories Limited | 141.4 Million INR | 88.434% |
| Gujarat Themis Biosyn Limited | 1.28 Billion INR | 98.724% |
| Hindustan Bio Sciences Limited | 3.14 Million INR | -420.82% |
| Ishita Drugs and Industries Limited | 38.94 Million INR | 58.001% |
| Jenburkt Pharmaceuticals Limited | 1.1 Billion INR | 98.524% |
| KIMIA BIOSCIENCES LIMITED | 111.76 Million INR | 85.366% |
| Kwality Pharmaceuticals Limited | 1.43 Billion INR | 98.862% |
| Makers Laboratories Limited | 308.54 Million INR | 94.699% |
| Medi-Caps Limited | 68.09 Million INR | 75.981% |
| MedPlus Health Services Limited | 12.33 Billion INR | 99.867% |
| Panchsheel Organics Limited | 356.44 Million INR | 95.412% |
| Parmax Pharma Limited | 99.31 Million INR | 83.533% |
| Parnax Lab Limited | 552.1 Million INR | 97.038% |
| Patidar Buildcon Limited | -26 Thousand INR | 63003.846% |
| Phaarmasia Limited | 38.89 Million INR | 57.945% |
| PRAVEG LIMITED | 266.99 Million INR | 93.874% |
| Sunil Healthcare Limited | 247.86 Million INR | 93.402% |
| Syschem (India) Limited | 569.04 Million INR | 97.126% |
| Sanjivani Paranteral Limited. | 208.87 Million INR | 92.17% |
| Sastasundar Ventures Limited | 1.19 Billion INR | 98.637% |
| SHAMROCK INDUSTRIAL CO.LTD. | -406 Thousand INR | 4128.325% |
| Smruthi Organics Limited | 324.76 Million INR | 94.964% |
| Source Natural Foods and Herbal Supplements Limited | 66.01 Million INR | 75.224% |
| SUDARSHAN PHARMA INDUSTRIES LI | 361.76 Million INR | 95.479% |
| Trident Lifeline Limited | 119.08 Million INR | 86.266% |
| Transchem Limited | -8.96 Million INR | 282.411% |
| Trinity League India Limited | 1.23 Million INR | -1227.516% |
| Tyche Industries Limited | 290.84 Million INR | 94.377% |
| Vikram Thermo (India) Limited | 443.73 Million INR | 96.314% |
| Vista Pharmaceuticals Limited | 10.02 Million INR | -63.224% |
| Vivanza Biosciences Limited | 19.38 Million INR | 15.639% |
| Zenith Healthcare Limited | 46.17 Million INR | 64.58% |
| Zenlabs Ethica Limited | 147.75 Million INR | 88.931% |
| Mercury Laboratories Limited | 279.39 Million INR | 94.146% |
| SHELTER PHARMA LIMITED | 110.97 Million INR | 85.262% |
| Vasundhara Rasayans Limited | 207.68 Million INR | 92.125% |
| Bharat Immunologicals & Biologicals Corporation Limited | -146.67 Million INR | 111.15% |
| Roopa Industries Limited | 72.95 Million INR | 77.581% |
| PANJON LTD. | 33.77 Million INR | 51.582% |
| Pharmaids Pharmaceuticals Limited | -72.81 Million INR | 122.46% |
| TIAAN CONSUMER LIMITED | -17.81 Million INR | 191.83% |
| Anuh Pharma Limited | 1.6 Billion INR | 98.98% |
| Crestchem Limited | 51.53 Million INR | 68.266% |
| Emmessar Biotech & Nutrition Limited | -7.43 Million INR | 320.032% |
| Sandu Pharmaceuticals Limited | 347.1 Million INR | 95.288% |
| Fredun Pharmaceuticals Limited | 724.71 Million INR | 97.743% |
| Trimurthi Limited | 1.95 Million INR | -738.288% |
| Shukra Pharmaceuticals Limited | 300.38 Million INR | 94.555% |
| Norris Medicines Limited | 29.36 Million INR | 44.299% |
| Veerhealth Care Limited | 49.57 Million INR | 67.009% |
| Lactose (India) Limited | 230.3 Million INR | 92.899% |
| OXYGENTA PHARMACEUTICAL LIMITE | -99.79 Million INR | 116.389% |
| Ambalal Sarabhai Enterprises Limited | 717.63 Million INR | 97.721% |
| Gennex Laboratories Limited | 276.99 Million INR | 94.096% |
| Denis Chem Lab Limited | 596.24 Million INR | 97.257% |
| Godavari Drugs Limited | 359.01 Million INR | 95.444% |
| Zenotech Laboratories Limited | 337.19 Million INR | 95.15% |
| Shree Ganesh Remedies Limited | 674.17 Million INR | 97.574% |
| Bharat Parenterals Limited | 989.46 Million INR | 98.347% |
| Coral Laboratories Limited | 332.39 Million INR | 95.08% |
| Evoq Remedies Limited | 47.43 Million INR | 65.521% |
| Kerala Ayurveda Limited | 447.69 Million INR | 96.347% |
| KOBO BIOTECH LIMITED | -40.71 Million INR | 140.17% |
| Natural Capsules Limited | 557.1 Million INR | 97.064% |
| Auro Laboratories Limited | 249.39 Million INR | 93.442% |